Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development (Q40949172)
scientific article published on June 1999
Language:
(P31) (Q13442814)
(P304) 17567-17572
(P407) (Q1860)
(P433) 25
(P478) 274
(P577) Tuesday, June 1, 1999
(P921) (Q33123)
(Q411114)
(P1433) (Q867727)
(P1476) "Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development" (language: en)
(P2093) I Quinto
M Mallardo
F Baldassarre
G Scala
G Englund
K T Jeang
(P2860) (Q33196552)
(Q45785662)
(Q36109349)
(Q33490720)
(Q45765427)
(Q45751494)
(Q29616404)
(Q29547822)
(Q34063826)
(Q52038970)
(Q39221310)
(Q47964346)
(Q28646883)
(Q45847022)
(Q29618434)
(Q41173886)
(Q27861101)
(Q29614709)
(Q24316905)
(Q29619514)
(Q29614707)
(Q29614706)
(Q29618717)
(Q37678595)
(Q36365371)
(Q30424775)
(Q45147943)
(Q41334618)
(Q41107175)
(Q59066353)
(Q73812679)
other details
description scientific article published on June 1999

External Links